Navigation Links
Immunomedics Announces Preclinical Therapy Results of SN-38 Immunoconjugate for Colorectal Cancer
Date:1/20/2009

SAN FRANCISCO, Jan. 20 /PRNewswire-FirstCall/ -- Immunomedics, Inc. (Nasdaq: IMMU), a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that results presented at the 2009 Gastrointestinal Cancers Symposium showed that labetuzumab-SN-38, an antibody-drug conjugate, selectively delivers SN-38 to human colon carcinoma in animal models as an effective new therapy.

SN-38 is the active metabolite of irinotecan, a chemotherapeutic agent approved by the FDA for the treatment of colorectal, lung, and other cancers. Due to its toxicity and poor solubility, SN-38 cannot be administered systemically to cancer patients. The Company has previously reported that by conjugating SN-38 to antibodies, the powerful cancer drug can be delivered selectively to tumors, thereby increasing the amount reaching the tumors and minimizing damage to normal tissues and organs. (Please refer to http://www.immunomedics.com/news_pdf/2008_PDF/PR03202008.pdf).

In this study, the therapeutic efficacy of SN-38 conjugated to labetuzumab was evaluated in two animal models of human colon cancer. Labetuzumab is a non-internalizing humanized antibody that binds to the carcinoembryonic antigen (CEACAM5) expressed by many solid cancers. The Company has conducted clinical trials with the naked and radiolabeled antibody in patients with colorectal, breast and pancreas cancers.

In a lung metastatic model of colon carcinoma, therapy with labetuzumab-SN-38 conjugate increased median survival time (MST) 1.9- to 3.4-fold compared to various controls, with 20% of animals alive at the end of the study. In another colon cancer model, MST for the immunoconjugate treatment group in
'/>"/>

SOURCE Immunomedics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP
2. Kyowa Hakko Kirin Announces Development Policy for Anti-Parkinsons Disease Drug KW-6002 (Istradefylline)
3. Intra-Cellular Therapies Announces Successful Outcome of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia
4. Beactica Announces Fragment-Based Drug Discovery Research Collaboration With GE Healthcare and Uppsala University
5. Amicus Therapeutics Announces Positive Progress of Three Lead Clinical Programs and General Outlook for 2009
6. NeurogesX Announces Publication of Phase 3 Data for QUTENZA(TM) (NGX-4010) in Postherpetic Neuralgia (PHN) by The Lancet Neurology
7. Pulmo BioTech Inc. Announces Dual Listing on Frankfurt Borse
8. Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference
9. Anesiva Announces FDA Approval of Supplemental New Drug Application to Expand Zingo(TM) Indication
10. ProUroCare Medical Inc. Announces Pricing of Equity Offering
11. Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... (Nasdaq: NKTR ) today reported its financial results ... Cash and investments in marketable securities at June 30, ... March 31, 2014."The second half of 2014 will be an ... milestones for a number of our late-stage clinical programs," said ... "The first of these is the potential US and EU ...
(Date:7/31/2014)... 31, 2014  UBM Medica US announces that ... for oncologists, presents exclusive slide shows dealing with communication ... quality cancer care. Cancer Network, ... offers news, blogs, and podcasts about the latest clinical ... care: , End-of-life care is challenging for ...
(Date:7/31/2014)... Mass. , July 31, 2014  Decision Resources ... technology market intelligence product Marketrack to now include ChinaTrack; ... device landscape in an interactive dashboard providing detailed ... procedure volumes at a hospital level. Other ... , Updated data feed: In addition to end-user surveys ...
Breaking Medicine Technology:Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 2Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 3Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 4Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 5Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 6Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 7Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 8Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 9Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 10Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 11Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 12Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 13Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 14Cancer Network Highlights Methods Oncologists Can Use to Improve Communication 2Cancer Network Highlights Methods Oncologists Can Use to Improve Communication 3Decision Resources Group Announces First Medical Device Account Targeting Tool in China 2
... SAN DIEGO, Jan. 11 CareFusion (NYSE: CFN ... the Food and Drug Administration (FDA) has given the company ... SE line of infusion pumps (also known as the Signature ... Medical Products division of Cardinal Health, has been operating under ...
... , PRINCETON, N.J., Jan. 11 Covance ... present at the 28th Annual J.P. Morgan Healthcare Conference on Wednesday, ... a live webcast of the presentation at www.covance.com . ... on 10 minutes early. , Covance, with headquarters in Princeton, New ...
Cached Medicine Technology:FDA Lifts Injunction on Manufacture and Sale of CareFusion Alaris(R) SE Pump 2
(Date:7/31/2014)... Ce-Classes.com has announced that they are now ... a Systematic Review of Sexual Satisfaction . ... International Journal of Clinical and Health Psychology. , This ... need to have accurate information about sexual satisfaction so ... The material provides a systematic review of 197 ...
(Date:7/31/2014)... In many states and counties across the country, ... life saving drugs. This requirement is for the safety of ... number of ambulances without proper security procedures. , In extreme ... even replaces the vital pain killers with saline. Later, the ... case in Baraboo, Wisconsin last November. According to court documents, ...
(Date:7/31/2014)... 2014 In today’s world, a good night’s ... Snoring and sleep apnea (a medical problem where the airway ... bed partners of the rest they need to face their ... snores and 20 million people in the United States alone ... and treated; and of those treated, many cannot tolerate their ...
(Date:7/31/2014)... Tampa, FL (PRWEB) July 31, 2014 ... 45 hospitals in the U.S. including Florida Hospital ... Term Acute Care, Florida Hospital North Pinellas, Florida ... Heartland Medical Center Sebring, Florida Hospital Heartland Medical ... Hospitals & Health Networks list of Most Wired ...
(Date:7/31/2014)... The vineyards are lush, and the grapes ... to celebrate, folks are gearing up for the annual ... 7, 2014 along the Leelanau Peninsula Wine Trail . ... run through the vineyards start-ing at 9:00 a.m. on Saturday ... course between rows of grapevines offers an experience like no ...
Breaking Medicine News(10 mins):Health News:Company Provides New Course on Sexual Satisfaction 2Health News:Company Provides New Course on Sexual Satisfaction 3Health News:New MedixSafe Alert - Ambulances Must Have A Medical Safe, Narcotics Cabinet, or Drug Locker 2Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Florida Hospital West Florida Region is Among the Most Wired Hospitals and Health Systems in the United States 2Health News:Leelanau Peninsula’s Annual Harvest Stompede Offers a Unique Vineyard Course for Walkers, Runners and Wine Tasters 2
... help decrease wait time, increase physician productivity,and ... reduce overcrowding,decrease patient wait time, and improve ... endorsed 10 national voluntary consensus standards for,hospital-based ... improve,efficiency and care coordination in emergency departments ...
... out for,the soccer team or training for a dance ... greater than adults. After all, they need,nutrition for growth ... from the foods they consume., Nutritious snacks that ... to,helping young athletes perform at their best. Portable snacks ...
... often must make 2009 plan choices in November, SOUTH ... candidates to choose from at this time of year. For ... usually the,time of the year when they have to choose ... effect in 2009., Many Maine companies offer between two ...
... DALLAS, Oct. 30 Claimsnet.com inc. (OTC,Bulletin Board: CLAI), ... healthcare industry, today reported its,results for the third quarter ... are pleased to report a 27% increase in our ... Claimsnet.,"The increase in overall costs during the third quarter ...
... One errant cough or unexpected,sneeze and the workplace ... As the flu season approaches, HR managers prepare to,deal ... estimates that the cost of influenza to the U.S. ... can range from $71 billion,to $167 billion a year., ...
... VANCOUVER, Oct. 30 /PRNewswire-FirstCall/ - Response Biomedical,Corporation (TSX: ... RAMP(R),technology in the 3M(TM) Rapid Detection Flu A+B ... in Washington D.C., officially launching,the RAMP(R) Influenza A/B ... branded,by 3M as the 3M(TM) Rapid Detection Flu ...
Cached Medicine News:Health News:NQF Endorses Measures to Address Care Coordination and Efficiency in Hospital Emergency Departments 2Health News:NQF Endorses Measures to Address Care Coordination and Efficiency in Hospital Emergency Departments 3Health News:Fueling Kids for Sports 2Health News:Health Insurance Open Enrollment Tips 2Health News:Health Insurance Open Enrollment Tips 3Health News:Claimsnet.com Reports Third Quarter 2008 Results 2Health News:Claimsnet.com Reports Third Quarter 2008 Results 3Health News:Going 'Green' May Mean Fewer Colds This Season 2Health News:Going 'Green' May Mean Fewer Colds This Season 3Health News:Response Biomedical Announces Launch of RAMP(R) Technology in 3M(TM) Rapid Detection Flu A+B Test at ICAAC/IDSA Conference 2Health News:Response Biomedical Announces Launch of RAMP(R) Technology in 3M(TM) Rapid Detection Flu A+B Test at ICAAC/IDSA Conference 3Health News:Response Biomedical Announces Launch of RAMP(R) Technology in 3M(TM) Rapid Detection Flu A+B Test at ICAAC/IDSA Conference 4
Liberty Single Piece PMMA Lens with UV Absorber....
... sterile nonpyrogenic, transparent viscoelastic solution of highly ... mg/ml of high molecular weight (greater than ... physiological saline. In the limit of zero ... (105 Pa s) at 25 C and ...
... with optimum molecular weight and viscosity, so ... coats and protects the delicate structures of ... balance of cohesion, adhesion, and pseudoplasticity to ... phaco surgeon expects from an ophthalmic viscoelastic ...
... (1.8%) viscoelastic solution combines maximum intraocular protection ... a deep anterior chamber and protects the ... for routine cataract surgery but can be ... viscoelastic. Combine all these properties with the ...
Medicine Products: